Moderna Resolves Global Patent Litigation with Arbutus/Genevant

Moderna to pay $950 million with no future royalties to resolve all global litigation; corresponding charge expected in Q1 2026 District Court's Section 1498 decision to be appealed to the Federal Circuit Court of Appeals with potential additional payment contingent on the outcome; no accrual recorded for potential additional payment as loss is not considered probable 2026 year-end cash and cash equivalents now expected to be in the range of $4.5 - $5.0 billion CAMBRIDGE, MA / ACCESS Newswire / March 3, 202 ...